`
`EXHIBIT B
`
`PETITIONER'S EXHIBITS
`
`Exhibit 1003 Page 253 of 1040
`
`PETITIONER'S EXHIBITS
`
`Exhibit 1003 Page 253 of 1040
`
`
`
`REFERENCES CONSIDERED BY DR. EDUARDO A. PADLAN
`
`Exhibit No.
`
`1001
`
`Description
`
`U.S.Pate nt N o.6 ,4 07,213 , Method for making humanized
`antibodies (file d Ju l.17, 1993 ) (issu e d Ju ne 18, 2002)
`
`1002Part I
`
`F ile H istory forU.S.Pate nt N o.6 ,4 07,213 Part I
`
`1002Part II
`
`F ile H istory forU.S.Pate nt N o.6 ,4 07,213 Part II
`
`1003
`
`1003 A
`
`1003 B
`
`1003 C
`
`1004
`
`1004 A
`
`1004 B
`
`1021
`
`1022
`
`103 0
`
`103 1
`
`D e c laration ofD r.Ed u ard oA .Pad lan in Su pport ofPe tition for
`Inter Partes Re vie w ofPate nt N o.6 ,4 07,213
`
`Curriculum Vitae ofD r.Ed u ard oA .Pad lan
`
`M ate rialsRe vie we d by D r.Ed u ard oA .Pad lan
`
`ExhibitsA -M ofD r.Ed u ard oA .Pad lan
`
`D e c laration ofProfe ssorEd ward Ball, M .D .in Su pport of
`Pe tition forInter Partes Re vie w ofPate nt N o.6 ,4 07,213
`
`Curriculum Vitae ofProfe ssorEd ward Ball, M .D .
`
`M ate rialsRe vie we d by Profe ssorEd ward Ball, M .D .
`
`H u d ziak e t al.p185HER2 Monoclonal Antibody Has
`Antiproliferative Effects In Vitro and Sensitizes Human Breast
`Tumor Cells to Tumor Necrosis Factor. M ol.C e llBiol.
`9(3 ):116 5 -1172(M arc h1989)
`
`K öhle rand M ilste in, Continuous Cultures of Fused Cells
`Secreting Antibody of Predefined Specificity. N atu re
`25 6 (5 5 17):4 95 -4 97 (A u gu st 7, 1975 )
`
`“Prote in D ataBank –C hronology”at
`https://www.nsf.gov/ne ws_su m m .jsp? c ntn_id =1006 89(ac c e sse d
`A u gu st 29, 2016 )
`
`M orrison e t al., Chimeric Human Antibody Molecules: Mouse
`Antigen-Binding Domains with Human Constant Region
`
`-1-
`
`PETITIONER'S EXHIBITS
`
`Exhibit 1003 Page 254 of 1040
`
`
`
`Exhibit No.
`
`Description
`Domains. Pro.N at’lA c ad .Sc i.81:6 85 1-6 85 5 (N ove m be r1984 ).
`
`103 3
`
`103 4
`
`104 5
`
`104 6
`
`104 7
`
`104 8
`
`104 9
`
`105 0
`
`105 1
`
`105 2
`
`Jone se t al.Replacing the Complementarity-Determining Regions
`in a Human Antibody with those from a Mouse. N atu re 3 21:5 22-
`5 25 (1986 )
`
`Qu e e n e t al.A Humanized Antibody that Binds to the Interleukin
`2 Receptor. Pro.N at’lA c ad .Sc i.86 :10029-1003 3 (1989)
`
`Slam on, D .J.e t al.Human Breast Cancer Correlation of Relapse
`and Survival with Amplification of the HER-2/neu Oncogene.
`Sc ie nc e 23 5 :177-182(1987)
`
`K rau s, M .H ., e t al.Overexpression of the EGF receptor-related
`proto-oncogene erbB-2 in human mammary tumor cell lines by
`different molecular mechanisms. The EM BOJou rnal6 (3 ):6 05 -
`6 10(1987)
`
`H u d ziak, R.M ., e t al.Increased expression of the putative
`growth factor receptor p185HER2 causes transformation and
`tumorigenesis of NIH 3T3 cells. Pro.N at’lA c ad .Sc i.84 :715 9-
`716 3 (1987)
`
`She pard , H .M .e t al.Monoclonal Antibody Therapy of Human
`Cancer: Taking the HER2 Protooncogene to the clinic. Jou rnal
`ofC linic alIm m u nology, 11(3 ):117-127 (1991).
`
`C hothia, C .e t al.Conformations of immunoglobulin
`hypervariable regions. N atu re 3 4 2(21):877-883 (D e c e m be r
`1989).
`
`Qu e e n, C ary L .:Inte rnationalPu blic ation N o.W O1990/0786 1
`(pu blishe d Ju ly 26 , 1990)
`
`Tram ontano, A .e t al.Framework Residue 71 is a Major
`Determinant of the Position and Conformation of the Second
`Hypervariable Region in the VH Domains of Immunoglobulins, J.
`M ol.Biol.215 :175 -182(1990)
`K abat, e t al.Sequences of Proteins of Immunological Interest 4th
`
`-2-
`
`PETITIONER'S EXHIBITS
`
`Exhibit 1003 Page 255 of 1040
`
`
`
`Exhibit No.
`
`105 3
`
`105 5
`
`105 7
`
`105 8
`
`105 9
`
`106 0
`
`106 1
`
`106 2
`
`106 3
`
`Description
`Ed., Tabulation and Analysis of Amino Acid and Nucleic Acid
`Sequences of Precursors, V-Regions, C-Regions, J-Chain, T-Cell
`Receptor for Antigen, T-Cell Surface Antigens (N ational
`Institu te sofH e alth, Be the sd a, M d .) (1987)
`
`W u and K abat, An analysis of the sequences of the variable
`regions of Bence Jones proteins and myeloma light chains and
`their implications for antibody complementarity. J.Exp.M e d .
`13 2:211-25 0(1970)
`K abat, e t al.Sequences of Proteins of Immunological Interest 5 th
`Ed., Tabulation and Analysis of Amino Acid and Nucleic Acid
`Sequences of Precursors, V-Regions, C-Regions, J-Chain, T-Cell
`Receptor for Antigen, T-Cell Surface Antigens (N ational
`Institu te sofH e alth, Be the sd a, M d .) (1991)
`
`Johnson and W u The Kabat database and a bioinformatics
`example, M e thod sin M ole c u larBiology 24 8:11-25 (D e c e m be r
`2003 )
`
`D avie s& M e tzge r, Structural Basics of Antibody Function,
`A nnu .Re v.Im m u nol.1:87-117 (1983 )
`
`A m it e t al.Three-Dimensional Structure of an Antigen-Antibody
`Complex at 2.8 A Resolution Sc ie nc e 23 3 :74 7-5 3 (1986 )
`
`L asc om be e t al.Three-dimensional Structure of Fab R19.9, a
`Monoclonal Murine Antibody Specific for the p-
`azobenzenearsonate group. Pro.N at’lA c ad .Sc i.86 :6 07-6 11
`(Janu ary 1989)
`
`N ovotný e t al.Molecular Anatomy of the Antibody Binding Site.
`J.Biol.C he m .25 8(23 ):14 4 3 3 -14 4 3 7 (D e c e m be r10, 1983 )
`
`L e sk 1987, Canonical structures for the hypervariable
`C hothia&
`regions of immunoglobulins.J.M ol.Biol.196 :901-917 (1987)
`
`C hothiae t al.Domain Association in Immunoglobulin
`Molecules: The Packing of Variable Domains.J.M ol.Biol.
`186 :6 5 1-6 3 (1985 )
`
`-3 -
`
`PETITIONER'S EXHIBITS
`
`Exhibit 1003 Page 256 of 1040
`
`
`
`Exhibit No.
`
`Description
`
`106 4
`
`106 5
`
`106 6
`
`106 7
`
`106 8
`
`106 9
`
`1070
`
`1071
`
`1072
`
`1073
`
`Van K roone nbu rgh& Pau we ls Human Immunological Response
`to Mouse Monoclonal Antibody Treatment or Diagnosis of
`Malignant Diseases.N u c l.M e d .C om m u n.9:919-3 0(1988)
`
`Tjand rae t al.Development of human anti-murine antibody
`(HAMA) response in patients.Im m u nol.C e ll.Biol.6 8:3 6 7-76
`(1990)
`
`L ind , e t al.Development of human antimouse antibodies
`(HAMA) after single and repeated diagnostic application of
`intact murine monoclonal antibodies. A ntibod .Im m u noc onj.
`Rad iopharm .4 (4 ):811-818 (1991)
`
`M ou ntain and A d air, Engineering Antibodies for Therapy.
`Biote c h.Ge ne t.Eng.Re v.10:1-14 2(1992)
`
`Ve rhoe ye n, M ilste in & W inte re t al.Reshaping Human
`Antibodies: Grafting an Antilysozyme Activity. Sc ie nc e
`23 9:15 3 4 -15 3 6 (M arc h25 , 1988)
`
`Rie c hm ann, e t al.Reshaping human antibodies for therapy.
`N atu re 3 3 2:3 23 -3 27 (M arc h24 , 1988)
`
`Te m pe st, e t al.Reshaping a human monoclonal antibody to
`inhibit human respiratory syncytial virus infection in vivo.
`BioTe c hnology 9:26 6 -271(M arc h1991)
`
`K u rrle , e t al.Improved monoclonal antibodies against the human
`alphabeta T-Cell receptor, their production and use. EP04 03 15 6 .
`(1990)
`
`She arm an, e t al.Construction, expression and characterization of
`humanized antibodies directed against the human a/b T cell
`receptor. J.Im m u nol.14 7(12):4 3 6 6 -4 3 73 , (D e c e m be r15 , 1991)
`
`W inte r, Gre gory Pau le t al.EP Pu blic ation N u m be r023 94 00,
`Recombinant antibodies and methods for their productions.
`Pu blishe d Se pte m be r3 0, 1987.
`
`-4 -
`
`PETITIONER'S EXHIBITS
`
`Exhibit 1003 Page 257 of 1040
`
`
`
`Exhibit No.
`
`Description
`
`1076
`
`1077
`
`1078
`
`1079
`
`1080
`
`1081
`
`1082
`
`1083
`
`1085
`
`1086
`
`L oe w, G.e t al.Engergy-Conformational Studies of B-Endorphis:
`Identification of Plausible Folded Conformers.Int.J.Qu ant.
`C he m .Qu ant.Biol.15 :5 5 -6 6 (1988)
`
`Bru c c ole rie t al.Structure of antibody hpervariable loops
`reproduced by a conformational search algorithm. N atu re
`3 3 5 (6 ):5 6 4 -5 6 8 (1988)
`
`C hothiae t al.The Predicted Structure of Immunoglobulin D1.3
`and its Comparison with the Crystal Structure. Sc ie nc e N e w
`Se rie s, 23 3 (4 76 5 ):75 5 -75 8 (A u gu st 15 , 1986 )
`
`K abat e t al., Sequences of Proteins of Immunological Interest
`Tabulation and Analysis of Amino Acid and Nucleic Acid
`Sequences of Precursors, V-Regions, C-Regions, J-Chain, T-Cell
`Receptor for Antigen, T-Cell Surface Antigens (N ational
`Institu te sofH e alth, Be the sd a, M d .) (1983 ).
`
`Be rnste in e t al.The Protein Data Bank: A Computer-based
`Archival File for Macromolecular Structures.J.M ol.Biol.
`112:5 3 5 -5 4 2(1977)
`
`She riffe t al.Three-Dimensional Structure of an Antibody-
`Antigen Complex, Proc .N at’lA c ad .Sc i.U.S.A .84 :8075 (1987)
`
`M arqu art e t al.The three-dimensional structure of antibodies.
`Im m u n.Tod ay 3 (6 ):16 0-16 6 (1982)
`
`Sau le t al.Preliminary Refinement and Structural Analysis of the
`FAB Fragment from Human Immunoglobulin NEW at 2.0
`Angstroms Resolution.J.Biol.C he m .25 3 :5 85 (1978)
`
`Satow e t al.Phosphocholine Binding Immunogloubulin Fab
`McPC306 An X-ray Diffraction Study at 2•Å.J.M ol.Biol.
`190:5 93 -6 04 (1986 )
`
`H e rron e t al.Three-Dimensional Structure of a Flourescein-Fab
`Complex Crystallized in 2-Methyl-2,4-pentanediol.Prote ins
`5 :271-280(1989)
`
`-5 -
`
`PETITIONER'S EXHIBITS
`
`Exhibit 1003 Page 258 of 1040
`
`
`
`Exhibit No.
`
`Description
`
`1087
`
`1088
`
`1089
`
`1090
`
`1091
`
`1092
`
`1097
`
`1098
`
`1099
`
`1100
`
`Pad lan e t al.Structure of an antibody-antigen complex: crystal
`structure of the HYHEL-10 FAB-lysozyme complex. Proc .N at’l
`A c ad .Sc i.86 :5 93 8-5 94 2(A u gu st 1989)
`
`K u m are t al.Regulation of phosphorylation of the c-erbB-
`2/HER2 gene product by monoclonal antibody and serum growth
`factor(s) in human mammary carcinoma cells.M ol.C e ll.Biol.
`11(2):979-986 (F e bru ary 1991)
`
`Soom roe t al.C-erbB-2 expression in different histological types
`of invasive breast carcinoma.J.C lin.Pathol.4 4 :211-14 (1991)
`
`K e nne thH .Gou ld ing, A Biologist’s Guide to
`K e ithW ilson &
`Principles and Techniques of Practical Biochemistry, §Protein
`sequencing, 170-173 (3 rd e d ., 1986 )
`
`Ed e lm an e t al.The Covalent Structure of an Entire γG
`Immunoglobulin Molecule.Proc .N at’lA c ad .Sc i6 3 :78-85
`(196 9)
`
`C apra, J.D onald and K e hoe , K .M ic hae lVariable Region
`Sequences of Five Human Immunoglobulin Heavy Chains of the
`VHIII Subgroup: Definitive Identification of Four Heavy Chain
`Hypervariable Regions.Proc .N at’lA c ad .Sc i.71:84 5 -8 (1974 )
`
`Sam brook e t al., Molecular Cloning (2d e d ., C old SpringH arbor
`L aboratory Pre ss) (1989)
`
`D au ghe rty e t al., Polymerase chain reaction facilitates the
`cloning, CDR-grafting and rapid expression of a murine
`monoclonal antibody directed against the CD18 component of
`leukocyte integrins.N u c l.A c id sRe s.19(9):24 71-24 76 (M ay
`1991).
`
`Pad lan and K abat, Modeling of Antibody Combining Sites M e th.
`Enzym ol.203 :3 (1991)).
`
`C olm an e t al., Three-dimensional structure of a complex of
`antibody with influenza virus neuraminidase, N atu re 3 26 :3 5 8
`
`-6 -
`
`PETITIONER'S EXHIBITS
`
`Exhibit 1003 Page 259 of 1040
`
`
`
`Exhibit No.
`
`Description
`
`(1987)
`
`1101
`
`1102
`
`1103
`
`1104
`
`1105
`
`1106
`
`1107
`
`1108
`
`1109
`
`1110
`
`Tu lipe t al., Crystal structures of neuraminidase-antibody
`complexes, C old SpringH arborSym p.Qu ant.Biol.4 :25 7 (1989)
`
`Be nd e re t al., Immunogenicity, efficacy and adverse events of
`adalimumab in RA patients. Rhe u m atol.Int.27:26 9-74 (2007)
`
`Brie nt, Bru c e W .and N isonoff, A lfre d Quantitative
`investigations of idiotypic antibodies. IV. Inhibition by specific
`haptens of the reaction of anti-hapten antibody with its anti-
`idiotypic antibody, JExpM e d .13 2:95 1-6 2(1970)
`
`K oprowskie t al., Human anti-idiotype antibodies in cancer
`patients: Is the modulation of the immune response beneficial for
`the patient? Proc .N at’l.A c ad .Sc i.U.S.A .81:216 (1984 )
`
`C hanhe t al., Monoclonal anti-idiotypic antibody mimics the CD4
`receptor and binds human immunodeficiency virus, Proc .N at’l.
`A c ad .Sc i.U.S.A .84 :3 891(1987)
`
`Sc hroffe t al., Human Anti-Murine Immunoglobulin Responses in
`Patients Receiving Monoclonal Antibody Therapy, C anc e rRe s.
`4 5 :879(1985 )
`
`A bd ou e t al., Network Theory in Autoimmunity. In vitro
`suppression of serum anti-DNA by anti-idiotypic antibody in
`systemic lupus erythematosus, J.C lin.Inve st.6 7:1297 (1981)
`
`H arris, L .J.e t al.The three-dimensional structure of an intact
`monoclonal antibody for canine lymphoma, N atu re 3 6 0:3 6 9-72
`(1992)
`
`Jane way, C .A .e t al., IM M UN OBIOL OGY:TH E IM M UN E SYSTEM IN
`H EA L TH & D ISEA SE (4 the d ., Garland Sc ie nc e Pu blishing, N Y,
`(1999))
`
`Potte r, M .Immunoglobulin-producing tumors and myeloma
`proteins of mice, Physiol.Re v.5 2:6 3 1-719(1972)
`
`-7 -
`
`PETITIONER'S EXHIBITS
`
`Exhibit 1003 Page 260 of 1040
`
`
`
`Exhibit No.
`
`Description
`
`1111
`
`1112
`
`1113
`
`1114
`
`1115
`
`1116
`
`1117
`
`1118
`
`1119
`
`1120
`
`K abat K .A .and W u , T.T.Attempts to locate complementarity-
`determining residues in the variable positions of light and heavy
`chains A nn.N Y A c ad .Sc i.190:3 82-93 (1971);
`
`D .R.D avie se t al.A ntibod y-antige n c om ple xe s, Ann. Rev.
`Biochem. 5 9:4 3 9-73 (1990).
`
`Eppe t al., The molecular structure of a dimer composed of the
`variable portions of the Bence Jones protein REI refined at 2.0Å
`resolution, Bioc he m .14 :4 94 3 (1975 )
`M ian, I.S.Structure, function and properties of antibody binding
`sites, J.M ol.Biol.217:13 3 -5 1(1991)
`
`Poljak e t al.The three-dimensional structure of the fab fragment
`of a human myeloma immunoglobulin at 2.0-angstrom resolution,
`Proc .N at’lA c ad .Sc i.U.S.A .71:3 4 4 0-4 (1974 )
`
`Pad lan e t al.Model building studies of antigen binding sites: The
`hapten binding site of MOPC315 C old SpringH arborSym p.
`Qu ant.Biol.4 1:6 27-3 7 (1977))
`
`Bou lianne e t al.Production of functional chimaeric
`mouse/human antibody, N atu re 3 12:6 4 3 -6 (1984 )
`
`Pad lan, E.A .A possible procedure for reducing the
`immunogenicity of antibody variable domains while preserving
`their ligand-binding properties, M ol.Im m u nol.28:4 89-98 (1991)
`
`U.S.Pate nt N o.6 ,797,4 92Method for Reducing the
`Immunogenicity of Antibody Variable Domains (ve ne e ringof
`C D 18 m onoc lonalantibod ie s) (F ile d M arc h16 , 2001)(Issu e d
`Se pte m be r28, 2004 )
`
`Pad lan, Ed u ard oA ., Choosing The Best Framework To Use In
`The ‘Humanization’ Of An Antibody by CDR-Grafting:
`Suggestions From 3-D Structural Data. The 2nd A nnu alIBC
`Inte rnationalC onfe re nc e on A ntibod y Engine e ring.Om niSan
`D ie goH ote l, San D ie go, C A .(D e c e m be r16 -18, 1991)
`
`-8 -
`
`PETITIONER'S EXHIBITS
`
`Exhibit 1003 Page 261 of 1040
`
`
`
`Exhibit No.
`
`Description
`
`1121
`
`1122
`
`1123
`
`1124
`
`1125
`
`1126
`
`1127
`
`1128
`
`1129
`
`113 0
`
`Su he t al., The galactan-binding immunoglobulin Fab J539: an
`X-ray diffraction study at 2.6-Å resolution, Prote ins1:74 (1986 )
`
`U.S.Pate nt N o.5 ,792,85 2Polynucleotides Encoding Modified
`Antibodies with Human Milk Fat Globule Specificity
`(hu m anization ofm onoc lonalantibod ie sbind ingtohu m an m ilk
`fat globu le antige n) (F ile d N ove m be r16 , 1992) (Issu e d A u gu st
`11, 1998)
`
`U.S.Pate nt N o.5 ,889,15 7 Humanized B3 Antibody Fragments,
`Fusion Proteins, and Uses Thereof (hu m anization ofm onoc lonal
`antibod ie stoL e wisϒ-re late d c arbohyd rate antige n) (F ile d
`Oc tobe r28, 1994 ) Issu e d M arc h3 0, 1999)
`
`USPate nt N o.5 ,795 ,96 5 Reshaped human antibody to human
`interleukin-6 receptor (c laim ingpriority toA pril25 , 1991)
`(Issu e d A u gu st 18, 1998)
`
`F u re y e t al.Structure of a novel Bence-Jones protein (Rhe)
`fragment at 1.6 Å resolution, J.M ol.Biol.16 7:6 6 1-92(1983 )
`
`Se gale t al.The Three-Dimensional Structure of a
`Phosphorylcholine-Binding Mouse Immunoglobulin Fab and the
`Nature of the Antigen Binding Site, Proc .N at’lA c ad .Sc i.U.S.A .
`71:4 298 (1974 )
`
`Jone s, TA Diffraction methods for biological macromolecules.
`Interactive computer graphics: FRODO, M e th.Enzym ol.
`115 :15 7-71(1985 )
`
`C o, M .e t al.Humanized antibodies for antiviral therapy, Proc .
`N at’lA c ad .Sc i.U.S.A .88:286 9-73 (1991)
`
`http://www.e xc e ltric k.c om /othe rs/history-of-e xc e l/(ac c e sse d
`A u gu st 29, 2016 )
`
`U.S.Pate nt N o.4 ,891,76 2Method and Apparatus for Tracking,
`Mapping and Recognition of Spatial Patterns (F ile d F e bru ary 9,
`1988) (Issu e d Janu ary 2, 1990)
`
`-9-
`
`PETITIONER'S EXHIBITS
`
`Exhibit 1003 Page 262 of 1040
`
`
`
`Exhibit No.
`
`113 1
`
`Description
`
`W allic k, S.e t al.Glycosylation of a VH residue of a monoclonal
`antibody against α(1-6) dextran increases its affinity for antigen,
`J. Exp. Med. 16 8:1099-109(1988)
`
`-10-
`
`PETITIONER'S EXHIBITS
`
`Exhibit 1003 Page 263 of 1040
`
`